Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allo-SCT”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Not applicableStudy completedNCT02257905
What this trial is testing

Allo SCT in Amyloidosis Non-interventional Study

Who this might be right for
AL Amyloidosis
European Society for Blood and Marrow Transplantation 14
Testing effectiveness (Phase 2)Study completedNCT00578942
What this trial is testing

Allo Non-myeloablative SCT Utilizing Matched Family Member Stem Cells Purged Using Campath

Who this might be right for
LymphomaMyelomaLeukemia+2 more
David Rizzieri, MD 48
Not applicableWithdrawnNCT02812082
What this trial is testing

Web-based Patient Education Program to Manage Side Effects of Allogeneic Stem Cell Transplant

Who this might be right for
Allo-SCT PatientsAdult Allo-SCT Survivor
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00636909
What this trial is testing

Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders

Who this might be right for
AMLALLCML Chronic Phase, Accelerated Phase, or Blast Crisis+6 more
Beth Israel Deaconess Medical Center 25
Early research (Phase 1)Ended earlyNCT02985554
What this trial is testing

Phase I Study to Assess the Tolerability and Efficacy of Nivolumab in Patients With Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
University of Chicago 3
Early research (Phase 1)Ended earlyNCT01551043
What this trial is testing

Allo CART-19 Protocol

Who this might be right for
Acute Lymphocytic Leukemia
University of Pennsylvania 2
Not applicableLooking for participantsNCT07537738
What this trial is testing

Leukemia Stem Cell-based Assay to Predict Relapse and Survival in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)MLL Rearrangement
Peking University People's Hospital 210
Testing effectiveness (Phase 2)Active Not RecruitingNCT04476199
What this trial is testing

Venetoclax and Decitabine Assessment in Patients (≥60 - <75 Years) with Newly Diagnosed AML Eligible for Allo-SCT

Who this might be right for
Acute Myeloid Leukemia
Gruppo Italiano Trapianto di Midollo Osseo 100
Testing effectiveness (Phase 2)Looking for participantsNCT05917405
What this trial is testing

Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT

Who this might be right for
Acute Myeloid Leukemia in Remission
Nantes University Hospital 302
Not applicableUnknownNCT00935324
What this trial is testing

The Role of CK18F in Predicting Graft-Versus-Host Disease (GvHD)

Who this might be right for
Allo-SCT
Heidelberg University 120
Testing effectiveness (Phase 2)Looking for participantsNCT06453460
What this trial is testing

CMV-TCIP Directed Letermovir Prophylaxis After Allo-SCT

Who this might be right for
CMVAllogeneic Stem Cell Transplantation
University of California, Irvine 50
Not applicableNot Yet RecruitingNCT07289087
What this trial is testing

Patient-Reported Outcomes in Allogeneic Stem Cell Transplantation and CAR-T Therapy

Who this might be right for
Quality of LifePatient Reported Outcome (PRO)Allogeneic Blood and Marrow Transplantation (BMT)+1 more
Associazione Qol-one 162
Testing effectiveness (Phase 2)Study completedNCT04522895
What this trial is testing

IDH2-Post-Allo-Trial for Patients with IDH2-mut Myeloid Neoplasms After Allo-SCT

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic SyndromesChronic Myelomonocytic Leukemia+3 more
Heinrich-Heine University, Duesseldorf 50
Testing effectiveness (Phase 2)UnknownNCT03454984
What this trial is testing

SGI-110 and Donor Lymphocyte Infusions (DLI) After Allogeneic Stem Cell Transplantation

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid Leukemia
Groupe Francophone des Myelodysplasies 40
Not applicableStudy completedNCT04469985
What this trial is testing

Allogeneic Stem Cell Transplantation (ALLO-SCT) in Elderly: 17-years Retrospective GITMO Survey

Who this might be right for
Allogeneic Stem Cell Transplantation in Elderly Patients
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 2,061
Testing effectiveness (Phase 2)Study completedNCT03690115
What this trial is testing

Study of Ponatinib (Iclusig) for Prevention of Relapse After Allogeneic Stem Cell Transplantation (allo-SCT) in FLT3-ITD AML Patients

Who this might be right for
Leukemia, Myeloid, Acute
Versailles Hospital 23
Large-scale testing (Phase 3)Ended earlyNCT03391856
What this trial is testing

Prolonged Isolated Thrombocytopenia After Allo-SCT : N-acetyl-L-cysteine (NAC) Versus Supportive Therapy

Who this might be right for
ThrombocytopeniaStem Cell Transplant Complications
Peking University People's Hospital 15
Large-scale testing (Phase 3)UnknownNCT00002989
What this trial is testing

Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
European Organisation for Research and Treatment of Cancer - EORTC 207
Testing effectiveness (Phase 2)Ended earlyNCT00040417
What this trial is testing

Bone Marrow Transplant From Donor Using Less Toxic Conditioning for Patient With High Risk Hemoglobinopathies

Who this might be right for
Sickle Cell AnemiaHemoglobinopathyThalassemia
Baylor College of Medicine 15
Testing effectiveness (Phase 2)Study completedNCT01025505
What this trial is testing

Ph+/Bcr-Abl+ ALL Imatinib and Nilotinib Rotational Study

Who this might be right for
TreatmentStem Cell Transplantation
Gruppo Italiano Malattie EMatologiche dell'Adulto 40
Next Page